Zingerone Targets LKB1/AMPK to Block FcεRI-Dependent Mast Cell Degranulation and Anaphylaxis

Area of Science:

• Pharmacology
• Immunology
• Cell Biology

Background:

• AMP-activated protein kinase (AMPK) regulates metabolism and shows promise in treating metabolic and allergic diseases.
• Zingerone, found in ginger, has shown protective effects in various conditions through AMPK activation.
• Understanding Zingerone's anti-allergic mechanisms is crucial for developing new therapies.

Purpose of the Study:

• To investigate the anti-allergic activity of Zingerone.
• To elucidate the specific AMPK-dependent mechanisms underlying Zingerone's effects.
• To evaluate Zingerone's therapeutic potential for mast cell-mediated allergic diseases.

Main Methods:

• In vitro experiments assessed Zingerone's impact on FcεRI-mediated signaling pathways, mediator release, and calcium influx.
• In vivo studies utilized passive and systemic anaphylaxis models to evaluate Zingerone's efficacy.
• LKB1/AMPK activation was investigated as the key mechanism.

Main Results:

• Zingerone suppressed FcεRI-mediated phosphorylation of key signaling molecules (PLCγ1, Akt, ERK1/2, JNK, p38, IKK).
• It reduced mast cell degranulation markers (β-hexosaminidase), eicosanoid and pro-inflammatory cytokine release, and calcium influx.
• In vivo, Zingerone significantly attenuated anaphylactic reactions.

Conclusions:

• Zingerone effectively inhibits FcεRI-dependent mast cell activation and anaphylaxis.
• The anti-allergic effects are mediated through the LKB1/AMPK pathway.
• Zingerone demonstrates significant therapeutic potential for allergic diseases driven by mast cell activation.